FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209476276> ?p ?o ?g. }

• W3209476276 abstract "Osteolytic bone metastasis leads to skeletal‑related events, resulting in a decline in the patient activities and survival; therefore, it is important to understand the mechanism underlying bone metastasis. Recent studies have suggested that microRNAs (miRNAs or miRs) are involved in osteoclast differentiation and/or osteolytic bone metastasis; however, the roles of miRNAs have not been elucidated. In the present study, the roles of miRNAs in bone destruction caused by breast cancer metastasis were investigated in vitro and in vivo. miR‑16, miR‑133a and miR‑223 were transfected into a human breast cancer cell line, MDA‑MB‑231. The expression of osteolytic factors in conditioned medium (miR‑CM) collected from the culture of transfected cells was assessed. To evaluate the effects of miRNAs on osteoclast differentiation and activities, tartrate‑resistant acid phosphatase (TRAP) staining and bone resorptive assays were performed in osteoclasts following miR‑CM treatment. To create in vivo bone metastasis models for histological and morphometric evaluation, miRNA‑transfected MDA‑MB‑231 cells were transplanted into the proximal tibia of nude mice. Expression of osteolytic factors, including receptor activator for nuclear factor‑κB ligand (RANKL), interleukin (IL)‑1β, IL‑6, parathyroid hormone‑related protein (PTHrP), and tumor necrosis factor (TNF), was increased in miR‑16‑CM, whereas it was decreased in both miR‑133a‑CM and miR‑223‑CM. TRAP staining and bone resorptive assays revealed that osteoclast function and activities were promoted by miR‑16‑CM treatment, whereas they were suppressed by miR‑133a‑CM and miR‑223‑CM. Consistent with in vitro findings, in vivo experiments revealed that the overexpression of miR‑16 increased osteoclast activities and bone destruction in MDA‑MB‑231 cells, whereas the opposite results were observed in both miR‑133a‑ and miR‑223‑transfected MDA‑MB‑231 cells. Our results indicated that miR‑16 promoted osteoclast activities and bone destruction caused by breast cancer metastasis in the bone microenvironment, whereas miR‑133a and miR‑223 suppressed them. These miRNAs could be potential biomarkers and therapeutic targets for breast cancer bone metastasis." @default.
• W3209476276 created "2021-11-08" @default.
• W3209476276 creator A5000860759 @default.
• W3209476276 creator A5010848608 @default.
• W3209476276 creator A5013094913 @default.
• W3209476276 creator A5014458786 @default.
• W3209476276 creator A5019321843 @default.
• W3209476276 creator A5021371159 @default.
• W3209476276 creator A5026906519 @default.
• W3209476276 creator A5030625832 @default.
• W3209476276 creator A5035062633 @default.
• W3209476276 creator A5040597512 @default.
• W3209476276 creator A5047078434 @default.
• W3209476276 creator A5056378067 @default.
• W3209476276 creator A5060133259 @default.
• W3209476276 creator A5062511223 @default.
• W3209476276 creator A5071471987 @default.
• W3209476276 creator A5073970879 @default.
• W3209476276 date "2021-10-29" @default.
• W3209476276 modified "2023-10-13" @default.
• W3209476276 title "Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis" @default.
• W3209476276 cites W144423133 @default.
• W3209476276 cites W1914050750 @default.
• W3209476276 cites W1944909911 @default.
• W3209476276 cites W1963853602 @default.
• W3209476276 cites W1974127760 @default.
• W3209476276 cites W1994097106 @default.
• W3209476276 cites W2002688520 @default.
• W3209476276 cites W2003762247 @default.
• W3209476276 cites W2022233074 @default.
• W3209476276 cites W2025250479 @default.
• W3209476276 cites W2027839585 @default.
• W3209476276 cites W2030487571 @default.
• W3209476276 cites W2037340119 @default.
• W3209476276 cites W2054148405 @default.
• W3209476276 cites W2054351138 @default.
• W3209476276 cites W2055984940 @default.
• W3209476276 cites W2063025597 @default.
• W3209476276 cites W2083072996 @default.
• W3209476276 cites W2084102864 @default.
• W3209476276 cites W2086519328 @default.
• W3209476276 cites W2087324367 @default.
• W3209476276 cites W2087484885 @default.
• W3209476276 cites W2092614678 @default.
• W3209476276 cites W2107277218 @default.
• W3209476276 cites W2107925338 @default.
• W3209476276 cites W2121867073 @default.
• W3209476276 cites W2124281312 @default.
• W3209476276 cites W2124758627 @default.
• W3209476276 cites W2125553683 @default.
• W3209476276 cites W2136257629 @default.
• W3209476276 cites W2141884093 @default.
• W3209476276 cites W2152091242 @default.
• W3209476276 cites W2156322485 @default.
• W3209476276 cites W2162674813 @default.
• W3209476276 cites W2172618366 @default.
• W3209476276 cites W2221106178 @default.
• W3209476276 cites W2287449522 @default.
• W3209476276 cites W2297872445 @default.
• W3209476276 cites W2328198526 @default.
• W3209476276 cites W2655221974 @default.
• W3209476276 cites W2753109313 @default.
• W3209476276 cites W2771016115 @default.
• W3209476276 cites W2787812668 @default.
• W3209476276 cites W2801631929 @default.
• W3209476276 cites W2893502863 @default.
• W3209476276 cites W2914224011 @default.
• W3209476276 cites W2917837889 @default.
• W3209476276 cites W2954955475 @default.
• W3209476276 cites W2973985163 @default.
• W3209476276 cites W2982337925 @default.
• W3209476276 cites W3012307045 @default.
• W3209476276 cites W3026254965 @default.
• W3209476276 cites W3045786341 @default.
• W3209476276 cites W3159942698 @default.
• W3209476276 cites W1964184380 @default.
• W3209476276 doi "https://doi.org/10.3892/ijo.2021.5277" @default.
• W3209476276 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8562387" @default.
• W3209476276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34713296" @default.
• W3209476276 hasPublicationYear "2021" @default.
• W3209476276 type Work @default.
• W3209476276 sameAs 3209476276 @default.
• W3209476276 citedByCount "3" @default.
• W3209476276 countsByYear W32094762762022 @default.
• W3209476276 countsByYear W32094762762023 @default.
• W3209476276 crossrefType "journal-article" @default.
• W3209476276 hasAuthorship W3209476276A5000860759 @default.
• W3209476276 hasAuthorship W3209476276A5010848608 @default.
• W3209476276 hasAuthorship W3209476276A5013094913 @default.
• W3209476276 hasAuthorship W3209476276A5014458786 @default.
• W3209476276 hasAuthorship W3209476276A5019321843 @default.
• W3209476276 hasAuthorship W3209476276A5021371159 @default.
• W3209476276 hasAuthorship W3209476276A5026906519 @default.
• W3209476276 hasAuthorship W3209476276A5030625832 @default.
• W3209476276 hasAuthorship W3209476276A5035062633 @default.
• W3209476276 hasAuthorship W3209476276A5040597512 @default.
• W3209476276 hasAuthorship W3209476276A5047078434 @default.
• W3209476276 hasAuthorship W3209476276A5056378067 @default.
• W3209476276 hasAuthorship W3209476276A5060133259 @default.
• W3209476276 hasAuthorship W3209476276A5062511223 @default.

• next